These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Schizophrenia and obsessive-compulsive disorder--some considerations based on a case]. Sümeg S; Herold R; Tényi T Psychiatr Hung; 2005; 20(1):35-9. PubMed ID: 16389732 [TBL] [Abstract][Full Text] [Related]
4. Anti-androgenic treatment of obsessive-compulsive disorder: an open-label clinical trial of the long-acting gonadotropin-releasing hormone analogue triptorelin. Eriksson T Int Clin Psychopharmacol; 2007 Jan; 22(1):57-61. PubMed ID: 17159461 [TBL] [Abstract][Full Text] [Related]
5. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol. Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614 [TBL] [Abstract][Full Text] [Related]
6. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms. Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353 [No Abstract] [Full Text] [Related]
9. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms. Ma N; Tan LW; Wang Q; Li ZX; Li LJ Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595 [TBL] [Abstract][Full Text] [Related]
10. [Quality of life in patients with obsessive-compulsive disorder: relations with cognitive functions and clinical symptoms]. Kivircik Akdede BB; Alptekin K; Akvardar Y; Kitiş A Turk Psikiyatri Derg; 2005; 16(1):13-9. PubMed ID: 15793694 [TBL] [Abstract][Full Text] [Related]
11. [Mental disorders associated with multiple sclerosis]. Wilkening A; Haltenhof H Dtsch Med Wochenschr; 2006 Jan; 131(4):154-8. PubMed ID: 16429337 [TBL] [Abstract][Full Text] [Related]
12. Symmetry, ordering and arranging compulsive behaviour. Radomsky AS; Rachman S Behav Res Ther; 2004 Aug; 42(8):893-913. PubMed ID: 15178465 [TBL] [Abstract][Full Text] [Related]
13. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder. Sevincok L; Topuz A J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120 [TBL] [Abstract][Full Text] [Related]
14. The presence of magical thinking in obsessive compulsive disorder. Einstein DA; Menzies RG Behav Res Ther; 2004 May; 42(5):539-49. PubMed ID: 15033500 [TBL] [Abstract][Full Text] [Related]
15. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647 [TBL] [Abstract][Full Text] [Related]
16. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases. Gabriëls L; Cosyns P; Nuttin B; Demeulemeester H; Gybels J Acta Psychiatr Scand; 2003 Apr; 107(4):275-82. PubMed ID: 12662250 [TBL] [Abstract][Full Text] [Related]
17. [Compulsive disorder with homicidal impulses and paranoid symptoms in vascular encephalopathy]. Brieger P; Bolling S Psychiatr Prax; 1997 Sep; 24(5):245-7. PubMed ID: 9417548 [TBL] [Abstract][Full Text] [Related]
18. The Vancouver Obsessional Compulsive Inventory (VOCI). Thordarson DS; Radomsky AS; Rachman S; Shafran R; Sawchuk CN; Ralph Hakstian A Behav Res Ther; 2004 Nov; 42(11):1289-314. PubMed ID: 15381439 [TBL] [Abstract][Full Text] [Related]
19. Obsessive-compulsive disorder and executive deficits in two patients with primary dystonia. Bugalho P; Correa B; Guimarães J; Xavier M Parkinsonism Relat Disord; 2006 Sep; 12(6):388-91. PubMed ID: 16731024 [TBL] [Abstract][Full Text] [Related]